News Â鶹´«Ă˝ from Stem Cells Translational Medicine Latest news from Stem Cells Translational Medicine on News en-us Copyright 2024 News News Â鶹´«Ă˝ from Stem Cells Translational Medicine 115 31 / /images/newswise-logo-rss.gif Correlation Between Genetic Abnormalities in Induced Pluripotent Stem Cell-Derivatives and Abnormal Tissue Formation in Tumorigenicity Tests /articles/correlation-between-genetic-abnormalities-in-induced-pluripotent-nbsp-stem-cell-derivatives-and-abnormal-tissue-formation-in-tumorigenicity-tests/?sc=rsin /articles/correlation-between-genetic-abnormalities-in-induced-pluripotent-nbsp-stem-cell-derivatives-and-abnormal-tissue-formation-in-tumorigenicity-tests/?sc=rsin Mon, 25 Apr 2022 04:00:30 EST Cell therapy using induced pluripotent stem cell (iPSC) derivatives may result in abnormal tissue generation because the cells undergo numerous cycles of mitosis before clinical application, potentially increasing the accumulation of genetic ... Stem Cells Translational Medicine Intraglandular Off-the-Shelf Allogeneic Mesenchymal Stem Cell Treatment in Patients with Radiation-Induced Xerostomia: A Safety Study (MESRIX-II) /articles/intraglandular-off-the-shelf-allogeneic-mesenchymal-nbsp-stem-cell-nbsp-treatment-in-patients-with-radiation-induced-xerostomia-a-safety-study-mesrix-ii/?sc=rsin /articles/intraglandular-off-the-shelf-allogeneic-mesenchymal-nbsp-stem-cell-nbsp-treatment-in-patients-with-radiation-induced-xerostomia-a-safety-study-mesrix-ii/?sc=rsin Mon, 25 Apr 2022 02:10:49 EST ... hold a patent application for the investigated stem cell product "Stem cell therapy based on adipose-derived stem cells", WO2017068140. None of the other coauthors declare conflicts of interest. LS is an advisory board member for Takeda and Kyowa ... Stem Cells Translational Medicine Current Status and Perspectives of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia /articles/current-status-and-perspectives-of-allogeneic-hematopoietic-nbsp-stem-cell-nbsp-transplantation-in-elderly-patients-with-acute-myeloid-leukemia/?sc=rsin /articles/current-status-and-perspectives-of-allogeneic-hematopoietic-nbsp-stem-cell-nbsp-transplantation-in-elderly-patients-with-acute-myeloid-leukemia/?sc=rsin Mon, 25 Apr 2022 02:10:49 EST As in younger patients, allogeneic stem cell transplantation (alloHSCT) offers the best chance for durable remission in older patients ( greater than or equal to 60 years) with acute myeloid leukemia (AML). However, defining the best treatment strategy (and in particular ... Stem Cells Translational Medicine Transient Inhibition of the JNK Pathway Promotes Human Hematopoietic Stem  Cell Quiescence and Engraftment /articles/transient-inhibition-of-the-jnk-pathway-promotes-human-hematopoietic-nbsp-stem-nbsp-cell-nbsp-quiescence-and-engraftment/?sc=rsin /articles/transient-inhibition-of-the-jnk-pathway-promotes-human-hematopoietic-nbsp-stem-nbsp-cell-nbsp-quiescence-and-engraftment/?sc=rsin Fri, 22 Apr 2022 04:00:02 EST The widespread clinical application of cord blood (CB) for hematopoietic stem  cell (HSC) transplantation is limited mainly by the inadequate number of hematopoietic stem and progenitor cells (HSPCs) in single CB units, which results in unsuccessful or ... Stem Cells Translational Medicine